Junwei Zeng Selected Research

Junwei Zeng Research Topics

Disease

5	Pain (Aches) 04/2022 - 09/2017
5	Hyperalgesia 04/2022 - 09/2017
4	Neuralgia (Stump Neuralgia) 01/2021 - 09/2017
2	Seizures (Absence Seizure) 12/2020 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 12/2016
2	IGA Glomerulonephritis (IGA Nephropathy) 10/2013 - 11/2012
2	Infections 08/2010 - 12/2007
2	Virus Diseases (Viral Diseases) 08/2010 - 04/2009
1	Hypersensitivity (Allergy) 04/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 12/2020
1	COVID-19 07/2020
1	Epilepsy (Aura) 01/2020
1	Cicatrix (Scar) 10/2019
1	Gliosis 10/2019
1	Fibrosis (Cirrhosis) 10/2019
1	Wounds and Injuries (Trauma) 10/2019
1	Peripheral Nerve Injuries 09/2017
1	Colitis 12/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2016
1	Tn Syndrome 10/2013
1	Carcinogenesis 10/2013
1	Neoplasms (Cancer) 11/2012
1	Human Influenza (Influenza) 04/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2017
2	Purinergic P2X ReceptorsIBA 04/2022 - 02/2018
2	ICI D2788IBA 04/2022 - 01/2021
2	Glutamic Acid (Glutamate)FDA Link 12/2020 - 01/2018
2	SB 203580IBA 12/2020 - 01/2018
2	CytokinesIBA 01/2018 - 12/2007
2	Immunoglobulin G (IgG)IBA 08/2010 - 04/2009
1	Purinergic P2X3 ReceptorsIBA 04/2022
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 04/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Cyclic NucleotidesIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020
1	p38 Mitogen-Activated Protein KinasesIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 07/2020
1	Kainic Acid (Kainate)IBA 01/2020
1	Pentylenetetrazole (Metrazol)IBA 01/2020
1	AMPA Receptors (AMPA Receptor)IBA 01/2020
1	NeurocanIBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019
1	Minocycline (Cyclops)FDA LinkGeneric 01/2019
1	purinoceptor P2Y6IBA 10/2018
1	N,N''- 1,4- butanediylbis(N'- (3- isothiocyanatophenyl))thioureaIBA 10/2018
1	Uridine Diphosphate (UDP)IBA 10/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2018
1	InterleukinsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	AcidsIBA 01/2018
1	MRS 2211IBA 01/2018
1	Excitatory Amino AcidsIBA 01/2018
1	Messenger RNA (mRNA)IBA 09/2017
1	adenosine 5'-O-(2-thiodiphosphate) (ADP-S)IBA 09/2017
1	CannabinoidsIBA 09/2017
1	Purinergic Receptors (Receptors, Purine)IBA 09/2017
1	AM 1241IBA 09/2017
1	CB2 Cannabinoid ReceptorIBA 09/2017
1	MucinsIBA 12/2016
1	Phenobarbital (Luminal)FDA Link 12/2016
1	Tumor Biomarkers (Tumor Markers)IBA 10/2013
1	AntigensIBA 10/2013
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 10/2013
1	Tn antigenIBA 11/2012
1	Immunoglobulin A (IgA)IBA 08/2010
1	Antiviral Agents (Antivirals)IBA 04/2009
1	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 04/2009
1	Immunoglobulin M (IgM)IBA 04/2009
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2009
1	LectinsIBA 04/2009
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007

Therapy/Procedure

3	Spinal Injections 04/2022 - 09/2017